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Background: The clinical features and the pathological changes of desmoid tumors were studied to point out the
key factors affecting the recurrence.
Methods: The clinical data and specimens of 56 patients who underwent desmoid tumor resection from 2003 to
2008 were reviewed. Possible clinical factors related to the postoperative recurrence were analyzed statistically. The
specimens round the lesions were studied histopathologically.
Results: The overall recurrence rate was 39.3%. The postoperative recurrence rate of the patients with negative
surgical margins and no tumor invasion of the major vessels and nerves was low (P < 0.05). However, the desmoid
tumors could destroy the cortical bone and invade the medullary cavity.
Conclusions: Desmoid tumors were pathologically benign, which could extensively invade tissues around the
lesions. The invasion of major vessels and nerves and quality of surgical margins are the key factors for the high
postoperative recurrence rate.
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Desmoid tumors, also known as hard fibroma, fibroma-
tosis, or aggressive fibromatosis, are rare soft tissue
tumors. Although desmoid tumors have few mitotic fig-
ures, their typical malignant features, such as a lack of
distant metastatic potential, locally aggressive growth,
and invasion of the surrounding tissues, make the full
resection very hard. Besides, their recurrence rate was
estimated ranging from 19% to 77% [1]. Surgery, in gen-
eral, was the major treatment for desmoid tumors.
Moreover, the combination of surgery, radiotherapy,
chemotherapy, and endocrinal therapy also has the abil-
ity to improve the clinical outcomes [2]. The quality of
the surgical margin was fatherly treated as the sole factor
affecting the local control rate [3]. The residue usually
locates between the tumor and the normal structures.
Noticeably, in order to increase the quality of the re-
section margins and decrease the recurrence rate, it is of
importance to study the invasion mechanism of desmoid
tumors into the surrounding structures. However, as far* Correspondence: guowpeking@gmail.com
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unless otherwise stated.as we know, reports about the clinical features of des-
moid tumors and the biological behaviors of the sur-
roundings are sporadic. Thus, we collected the clinical
data and pathological specimens of 56 desmoid tumor
patients with complete postoperative follow-up treat-
ment, analyzed the clinical features of the desmoid tu-
mors, and studied histopathologically their surrounding
structures to investigate the related clinical factors and
pathological mechanisms causing the postoperative re-
currence. Our aim was to provide the evidences for the
surgical treatment strategies.Methods
Clinical data
Clinical data and pathological specimens of 56 desmoid
tumor patients were collected at the Musculoskeletal
Tumor Center, Peking University People’s Hospital, P. R.
China, from February 2003 to December 2008. All the
patients returned for follow-up during a period ranging
from 33 to 108 months ending with tumor recurrence.
None of them was offered any preoperative radiotherapy
or pharmacotherapy. Twenty-six patients with primary
tumors and 30 with recurrent tumors were categorizedThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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them, 20 patients were male and 36 were female. The
youngest patient was 7 years old and the oldest was
76 (median 29.3). Lesions located either in the trunk
(16 cases) or in the limb (40 cases) (Table 1). The 16
trunk cases included eight pelvis, three retroperitoneals,
three backs, and two necks, whereas the 40 cases of limb
comprised 15 lower arms, 13 upper arms, eight hips,
and four shoulders.
Surgical treatment
All the surgeries were conducted by two senior surgeons
at the Musculoskeletal Tumor Center, Peking University
People’s Hospital, P. R. China. Tumors with pure soft
tissue involvement would receive a gross total resection,
whereas tumors invading major vessels and nerves, such
as popliteal vessels, sciatic nerve, and brachial plexitis,
would be preserved as much as possible after separation.
If the tumors fully circumscribed, the surrounding struc-
tures need to be removed completely to achieve the sat-
isfactory clinical margins. Artificial vascular graft would
be deployed if needed. In our study, the tumor sites in-
cluded eight sciatic nerves, four vascular nerve axillas,
two popliteal vessels, three ulnar nerves, three iliac ves-
sels, two neurovasculars, three median nerves, two ner-
vus peroneus communis, two radial nerves, two tibial
nerves, two vascular nerves, one lumbar nerve, one fem-
oral nerve, and one carotid artery and vein, respectively.
Lesion curettage would be offered if the tumors had
bone involvement. However, if the tumors circumscribed
and infected the diaphysis aggressively or the bone was
severely destroyed, the tumor segmental resection, in-
activation followed by bone graft and internal fixation,
or prosthetic replacement would be conducted (Table 2).
Patients with positive margins received radiotherapy at a
dose of 50 Gy [4], whereas the others were adminis-
trated with NSAIDs postoperatively. NSAIDs included
Celecoxib® (Pfizer, Inc., NY, USA) at a dose of 200 mg bidTable 1 General data of the 56 patients with desmoid
tumors








≥ 30 10 16
< 30 16 14
Tumor site
Limb 16 24
Trunk 10 6[5] and Raloxifene (Hongfuda Pharmaceutical Chemical
Ltd., Shandong, P. R. China) at a dose of 200 mg qd.
Noteworthy, Raloxifene is not eligible for pregnancy,
pregnancy planning, or immaturity [6,7]. Chemotherapy
alone was not applied as the treatment because it would
probably make the surgery more difficult, put the pa-
tients at risk of eccyliosis and limb contracture, and even
worse, induce tumor malignancy.
Pathological examination
Cross sections of desmoid tumors were made horizon-
tally and vertically, and then the tumors and their sur-
roundings were later observed. Different sections and
their around apparently normal tissue were sampled in
the boundary between the tumor and the adipose tissue,
muscle, anadesma, ligament, vessel, nerve, or bone. All
specimens were fixed for 24 h in formalin solution. Be-
sides, the specimens with bone involvement were decal-
cificated for at least another 48 h. Samples were sliced,
4 μm in width, after paraffin embedding. All the slices
were confirmed histologically: the pathological morph-
ology of desmoid tumors and their surroundings were
observed under the microscope by hematoxylin-eosin
staining (HE). The immunohistological staining method,
EnVision® two steps (Beijing Zhongshan Jinqiao Biotech-
nology Ltd., China), was then applied following the man-
ufacturer’s instruction. TBS was used as blank control,
and the positive slice was used as the positive control ac-
cording to the manufacturer’s recommendation. Positive
outcomes were determined if brownish yellow to brown
particles occurred in more than 10% of desmoid tumor
cell nuclei.
Postoperative follow-up
The patients with desmoid tumors were chosen to re-
ceive clinical follow-up during a postoperative period of
the 3rd, 6th, 9th, 12th, 18th, and 24th month, respect-
ively. Physical and radiological examination, such as
MRI or CT, would be deployed once a year afterward.
The postoperative recurrence was determined by the
recurrent encapsulation of the surgical site, the radio-
logical examination, and the pathological diagnosis. Tumor
size was measured based on the preoperative MRI or CT
images. The margin quality was categorized as negative
margins (R0) and the macroscopic or microscopic residues
of pathological changes (R1/2).
Statistical analysis
All the clinical and surgical treatment, pathological
examination, and postoperative follow-up were approved
by the Ethics Committee at the Musculoskeletal Tumor
Center, Peking University People’s Hospital, P. R. China
(No.PUPH2012900401). Gender, patient age, primary
treatment or recurrence, tumor site, tumor size, invasion
Table 2 Cases and surgical treatment of desmoid tumors with bone involvement
Tumor sites Cases Surgical treatments
Ilium and acetabulum 4 3 for lesion curettage, 1 for lesion curettage with bone grafting
Ulna and radius 3 2 for tumor segmental resection, inactivated with bone grafting and internal fixation, 1 for tumor
segmental resection with radius replaced by fibula
Pubis 3 2 for lesion curettage, 1 for inactivated bone grafting with internal fixation
Humerus 3 2 for lesion curettage with internal fixation, 1 for tumor resection with prosthetic replacement
Femur 2 1 for tumor resection with prosthetic replacement, 1 for lesion curettage with internal fixation
Clavicle 1 Lesion curettage
Tibia 1 Lesion curettage with internal fixation
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examination or surgery, bone involvement, quality of
surgical margins, adjuvant radiotherapy, and pharmaco-
therapy or not were analyzed statistically by SPSS 19.0.
The X2 test was used for univariate analysis. The multi-
factors logistic regression analysis would be deployed for
the independent factor determination if P < 0.10 in uni-
variate analysis. A P value of <0.05 was considered sig-
nificant for all analyses.
Results
Pathological examination
In general, the pathological changes were different in
size ranging from 3 to 17 cm (median 7 cm). Desmoid
tumors with opaque margins invaded the surrounding
muscles, adipose tissue, anadesma, ligaments, vessels,
and nerves, where the connection was tight and hard to
separate. The depression of bone surface pressed by theFigure 1 Desmoid tumor in the proximal part of the left thigh of a 29
white on the cut and often poorly circumscribed.tumor located at the connecting site in between. Macro-
scopically, the tumors were tenacious, yellowish white
on the cut. It was hard to distinguish them from the scar
tissue and ligament (Figure 1).
Histological characteristics
Microscopically, desmoid cells were spindle shaped or
swollen to some extent caused by cell proliferation
among massive collagen, small vessels, and the round
edema fibrous connective tissue (Figure 2a, arrows).
Opaque tumor cells had spindle to short spindle-shaped
nuclei with abundant cytoplasm. These cells were
slightly dysmorphic, arranging in bundles, accompanied
by rare nuclei mitotic figures occasionally with mucoid
degeneration and hyalinization (Figure 2a).
The muscle invasion and the degeneration of the
muscle cells were found around the tumors. Conse-
quently, the necrotic muscle cells were replaced by the-year-old woman. Macroscopically, desmoid tumors were yellowish
Figure 2 Histological features of desmoid tumors in the proximal part of the left thigh of a 29-year-old woman (arrows) (a–d). (a) Desmoid
tumors invaded into the skeletal striated muscle aggressively. Degeneration of skeletal muscle cells could be seen (HE × 100). (b) Budding-like protrusion
of the lesions invading into the muscles could be seen on the juncture of tumors and muscles (HE × 40). (c) Isolated small lesions in muscles were found
away from the main part of the tumor (HE × 40). (d) Microscopically, desmoid tumors were poorly circumscribed on tumor-ligament boundary (HE × 40).
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lesions were visibly invading into the muscles along the
connective tissues in the muscle bundles on the juncture
of tumors and muscles (Figure 2b). Isolated small lesions
in muscles were also found away from the main part of
the tumors (Figure 2c). When the tumors invaded the
anadesma, ligament, and scar tissue, there were no clear
margins in between (Figure 2d). Nevertheless, it was
even harder to separate the tumor cells from the normal
muscle tendon cells based on the cell morphology. The
tumor identification can only be made by the careful ob-
servation of the regular arrangement of the cells and the
progression of the tumors. Lesions with adipose tissue
involvement were also visible (Figure 3a). The tumor
invasion occurred in the connective tissue around the
vessel and nerve bundles like the outer membranes.
However, desmoid tumors around the vessels could not
penetrate the vessel wall to form the tumor embolus
(Figure 3b), whereas thicker nerve fibers were protected
by their outer membrane. Perineural space was defined
as the gap between the epineurium and the surrounding
connective tissue. Desmoid tumors invaded into the
connective tissue around the nerve bundles, perineural
space, and even perineurium, but not into the nervefibers (Figure 3c). Desmoid tumors with bone involve-
ment penetrated the periosteum and cortical bone and
invaded into the bone medullary cavity along the bone
trabecula (Figure 3d).
Immunohistochemical examination
Generally speaking, β-catenin staining, among all the
conventional stain methods for mesenchymal tumors,
has proven to be the most effective stain method for the
diagnosis of the desmoid tumors (data no shown). SMA
staining, β-catenin staining, and Vimentin staining were
positive in most lesions, whereas Ki-67 staining caused a
low positive ratio, and Desmin staining was negative.
Unexpectedly, β-catenin staining was rather specific
(Figure 4a–d).
Postoperative follow-up
Twenty two of the 56 patients with desmoid tumor
showed postoperative recurrent symptom, whereas the
other 34 were free of tumors. Thus, the recurrence rate
was 39.3%. Primary treatment group had a recurrence
rate of 30.7%, likewise which of the recurrent group was
46.7%. The relapse period ranged from 5 to 23 months
(median 17.3 months) in the primary treatment group,
Figure 3 Histological features of postoperative recurrent desmoid tumors in the right forearm of a 15-year-old man (arrows) (a–d).
(a) Lesions with adipose tissue involvement (HE × 40). (b) Desmoid tumors around vessels could not invade into the vessel wall to form tumor
thrombus (HE × 40). (c) Desmoid tumors invaded into the connective tissue and perineurium around nerve tissue (HE × 40). (d) Desmoid tumors
with bone involvement penetrated into the periosteum and cortical bone and invaded into the bone marrow cavity along the bone
trabecula (HE × 40).
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26 months (median 14.8 months).
Univariate analysis showed that gender, patient age,
primary treatment or recurrence, bone invasion, tumor
site, tumor size, pharmacotherapy, and radiotherapy had
no statistical significance on the recurrence (Table 3).
The invasion of the major vessels and the quality of the
surgical margins were statistically significant (P < 0.05,
X2 = 6.766, 9.008, respectively). According to the logistic
regression analysis, both aforementioned factors were
independent variables for the recurrence [major vessels
and nerves invasion P < 0.05, OR = 11.428, 95% CI
(1.936, 67.459) (Tables 3 and 4); quality of the surgical
margin P < 0.05, OR = 13.904, 95% CI (2.687, 71.951)].
Negative group had a lower recurrence rate (23.5%) than
the positive one (63.6%). The group, free of major vessels
and nerves, exhibited a lower recurrence rate (18.2%) than
that with the involvement (52.9%).
Discussion
Pathologically, it is easy to make a definite diagnosis of the
desmoid tumors based on their morphological fea-
tures and the immunohistochemical analyses of β-catenin.Budding-like lesions are visible on the juncture of desmoid
tumors and muscles, which invade muscles and around
adipose tissue aggressively along muscle bundles with the
formation of small free focal lesions.
However, it is very hard to find such macroscopic le-
sions. The positive surgical margins may recur only if
the resection is on the lesions themselves. Furthermore,
tendon transposition and musculocutaneous flap transfer
will be applied for partial reconstruction if the wide re-
section on the muscles causes the limb disturbance. In
the case of desmoid tumors with deltoid and triceps
muscle of arm involvement, Pruzansky et al. [8] removed
a large section along the entire deltoid and three quar-
ters of the triceps. The latissimus dorsi musculocuta-
neous flap was then applied to restore soft tissue and
muscle function. Gallucci et al. [9] reported a case of
aggressive fibromatosis in the proximal third of the fore-
arm treated by wide resection and reconstructive surgery
with no recurrence during a 3-year follow-up.
When the desmoid tumors invade the anadesma, liga-
ment, joint capsule, or scar tissue, there is no obvious
macroscopic boundary between the tumor cells and the
normal tissue cells. Even under the microscope, it is
Figure 4 Immunological features of desmoid tumors in the middle section of the left thigh of a 35-year-old woman with femur
involvement (a–d). (a) β-catenin staining of desmoid tumors (EnVision × 200). (b) Vimentin staining of desmoid tumors (EnVision × 200).
(c) Desmin staining of desmoid tumors (EnVision × 200). (d) Ki-67 staining of desmoid tumors (EnVision × 200).
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ones if only based on the morphological observation.
Therefore, during the surgery, a wider resection would
be made with caution to avoid the residual disease. In
terms of the recurrence patients, it is necessary to make
a full resection as much as possible to remove the previ-
ous surgical scar. Artificial reconstructive ligament was
not applied to restore the limb function and the joint
stability until partial ligament or joint capsule was re-
moved. In our study, the connective tissue around the
larger vessel-nerve bundles was infected by the desmoid
tumors, whereas the outer membranes of vessels and
nerves were also invaded with the preclusion of vessel
walls causing no tumor embolus.
The biological behavior of desmoid tumors is quite dif-
ferent from that of the other malignant tumors which
devastate the vessels to form tumor embolus resulting in
vascular metastasis. The reasons why desmoid tumors
do not metastasize are also based on their biological be-
havioral characteristics. The thicker nerve fibers circum-
scribed by the outer membranes formed the perineural
space, between which the around connective tissue lo-
cates. The tumors invade the around connective tissue
of the nerve bundles, then the perineural space, and
even the nerve bundle membrane. We also found thatthe small vessel and nerve branches were usually encap-
sulated by the tumors, which caused the outer mem-
brane invasion of the vessel-nerve bundle. The tumors
recur following the residue preservation. On the con-
trary, the surrounding connective tissues of the larger
vessel-nerve bundles were abundant with the function of
“protection.” If the tumors partially invade major vessels
and nerves, the macroscopic tumor foci need to be re-
moved and the vessels and nerves will be peeled off as
much as possible (e.g. epineurium resection) to preserve
the limb function. On the other hand, if the tissues re-
ceive a complete invasion, full resection of the tumors
and the surrounding structures has to be conducted to
decrease the recurrence rate. It may, however, be diffi-
cult for the functional reconstruction. Ferraresi et al.
[10] reported a rare case that the radial nerve selectively
invaded by the desmoid tumors was removed followed
by graft repair with normal postoperative function and
no recurrence during the 6-year follow-up. Desmoid tu-
mors destroy the periosteum on the juncture of tumors
and bones and then invade bone tissues along the bone
trabecula with aggressive growth in the medullary cavity.
Thus, partial bones will be removed, and the invasion of
the medullary cavity needs to be examined attentively
when the tumors and the bone tissues are close.
Table 3 Single-factor univariate analysis for the






(34 cases) (22 cases)
Gender
Male 12 8 0.935
Female 22 14
Patient age
< 30 18 8 0.224
≥ 30 16 14
Clinical condition
Primary tumor 18 8 0.224
Recurrence 16 14
Tumor site
Limb 26 14 0.299
Trunk 8 8
Tumor size
≤ 190 cm3 27 16 0.747
> 190 cm3 7 6
Major vessels and nerves invasion
No 18 4 0.020
Yes 16 18
Bone invasion
No 23 16 0.686
Yes 11 6
Margin quality
R0 26 8 0.007
R1/2 8 14
Radiotherapy
No 24 18 0.343
Yes 10 4
Medication
No 26 17 0.945
Yes 8 5
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17.3 months) in the primary treatment group, whereas
that of the recurrence group was from 3 to 26 months
(median 14.8 months). The recurrent patients presented
at year 2 except for one relapsed after 26 months.Table 4 Logistic regression analysis of the recurrence rate
of desmoid tumors
Factors OR value P value 95% CI
Major vessel and nerve invasion 11.428 0.007 1.936, 67.459
Margin quality 13.904 0.002 2.687, 71.951Different from the malignant tumors such as osteosar-
coma and chondrosarcoma, the relatively slow growth
makes the patients with desmoid tumors less sensitive to
radiotherapy or chemotherapy with late outcomes. As a
result, the treatment and the postoperative follow-up
should last at least 2 years.
The quality of surgical margins and the invasion of
major vessels and nerves are the two independent risk
factors causing the recurrence based on our statistical
analysis of the clinical documents. The quality of surgi-
cal margins has also been regarded as the key factor
affecting the postoperative outcomes. Nuyttens et al. [1]
demonstrated that the local control rate of the negative-
margin patient was higher than that of the positive with
the preclusion of adjuvant radiotherapy. Pignatii et al.
[3] found that the negative margins, rather than radio-
therapy, gender, patient age, and tumor site, was the only
factor to increase the local control rate. Mendenhall
et al. [11] reviewed 10-year postoperative patients with
surgery only and found that the local control rate of the
negative margins (73%) was significantly different from
that of the positive (46%). Thus, it is of critical import-
ance in achieving the wide resection margins to control
the desmoid recurrence rate.
Noticeably, the number of the chemotherapy cycle for
desmoid tumors have not reached consensus, even
though the newly developed adjuvant chemotherapy and
radiotherapy have been applied extensively during the
tumor treatment. Baliski et al. [12] reported a retrospect-
ive study on 13 desmoid tumor patients that 30 mg/day
Adriamycin was infused preoperatively for 3 days, and
then radiotherapy was used at a dose of 3000 cCy;
surgery was applied 4–6 weeks after. Only two patients
had a relapse during the average follow-up period of
71 months. The desmoid tumor control rate was as high
as 85%, which was significantly higher than that of previ-
ous reports. Hence, the combined treatment strategy of
preoperative chemotherapy and radiotherapy and sur-
gery would be better than the traditional treatment, in
other words, one of each aforementioned treatment [1].
Our study showed that the patients with desmoid
tumor with vessel and nerve involvement had a com-
paratively high recurrence rate. One reason could be the
vessels and nerves were preserved with their benign fea-
ture to avoid severe limb disturbance, which might leave
the residual lesions in the vessel-nerve bundle surround-
ings or even inside causing local recurrence. Therefore,
partial vessels and nerves need to be removed if neces-
sary followed by local reconstruction to achieve the
negative surgical margins.
Conclusions
Our data showed that either the positive surgical margin
or the tumors invading major vessels and nerves were
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therapeutic treatments are as follows: 1) simple soft tis-
sue tumors need wide resection; 2) tendon transposition
and musculocutaneous flap transfer will be conducted
for partial reconstruction resulting from the soft tissue
deficiency after wide resection; 3) if the tumors invade
major vessels and nerves, the outer membrane resection
for separation will be carried out to avoid severe distur-
bances; 4) when the tumors circumscribe vessels and
nerves, full resection should be applied followed by par-
tial reconstruction to cease the high recurrence rate;
5) if the tumors invade bone, lesion curettage, tumor
segmental resection, inaction with bone replantation, or
prosthetic replacement will be applied depending on the
condition. Noticeably, the lesions in the medullary cavity
should also be examined with caution. Briefly, radiother-
apy, pharmacotherapy and other treatments may be used
to control the local recurrence rate if the positive surgi-
cal margin or definitive surgery is not satisfying based
on their biological behavioral features.
Consent
Written informed consent was obtained from the patient
for the publication of this report and any accompanying
images.
Abbreviations
NSAIDs: Nonsteroidal anti-inflammatory drugs; HE: Hematoxylin-eosin
staining; TBS: Tris-buffered saline; MRI: Magnetic resonance imaging;
CT: Computed tomography; SMA: Smooth muscle actin.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
YFW developed the study concepts and drafted the manuscript. GW was
responsible for the design of the study and reviewed the manuscript. KKS
acquainted the data. RLY developed the algorithms. XDT analyzed and
interpreted the data. TJ and ST carried out the statistical analysis. All the
authors have read and approved the final manuscript.
Acknowledgements
The authors thank all of the patients who participated in this study.
Author details
1Musculoskeletal Tumor Center, Peking University People’s Hospital, Beijing
100044, P.R. China. 2Department of Pathology, Peking University People’s
Hospital, Beijing 100044, P.R. China.
Received: 13 June 2014 Accepted: 8 January 2015
References
1. Nuyttens JJ, Rust PF, Thomas CR, Turrisi III AT. Surgery versus radiation
therapy for patients with aggressive fibromatosis or desmoid tumors: a
comparative review of 22 articles. Cancer. 2000;88:1517–23.
2. Zhao DB, Shao YF. Abdominal wall desmoid tumor—a report of 53 cases.
Cancer Res on Prev Treat. 2000;27:674–5.
3. Pignatti G, Barbanti-Brodano G, Ferrari D, Gherlinzoni F, Bertoni F, Bacchini P,
et al. Extraabdominal desmoid tumor: a study of 83 cases. Clin Orthop Relat
Res. 2000;375:207–13.
4. Ballo MT, Zagars GK, Pollack A. Radiation therapy in the management of
desmoid tumors. Int J Radiat Oncol Biol Phys. 1998;42:1007–14.5. Tsukada K, Church JM, Jagelman DG, Fazio VW, McGannon E, George CR,
et al. Noncytotoxic therapy for intra-abdominal desmoid tumor in patients
with familial adenomatous polyposis. Dis Colon Rectum. 1992;35:29–33.
6. Chao AS, Lai CH, Hsueh S, Chen CS, Yang YC, Soong YK. Successful
treatment of recurrent pelvic desmoid tumor with tamoxifen: case report.
Hum Reprod. 2000;15:311–3.
7. Hansmann A, Adolph C, Vogel T, Unger A, Moeslein G. High-dose tamoxifen
and sulindac as first-line treatment for desmoid tumors. Cancer.
2004;100:612–20.
8. Pruzansky M, Kelly M, Weinberg H. Latissimus dorsi musculocutaneous flap
for elbow extension. J Surg Oncol. 1991;47:62–6.
9. Gallucci GL, Boretto JG, De Carli P. Desmoid tumor of the forearm:
reconstructive surgery and functional result. Chir Main. 2009;28:326–9.
10. Ferraresi S, Garozzo D, Bianchini E. Aggressive fibromatosis (desmoid tumor)
of the radial nerve: favorable resolution: case report. J Neurosurg.
2001;95:332–3.
11. Mendenhall WM, Zlotecki RA, Morris CG, Hochwald SN, Scarborough MT.
Aggressive fibromatosis. Am J Clin Oncol. 2005;28:211–5.
12. Baliski CR, Temple WJ, Arthur K, Norman SS. Desmoid tumors: a novel
approach for local control. J Surg Oncol. 2002;80:96–9.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
